CLDI·320703408·US·equity·Healthcare - Biotechnology-Activist
CLDI (CALIDI BIOTHERAPEUTICS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: HighTower Advisors, LLC ($19,945), GEODE CAPITAL MANAGEMENT, LLC ($15,048), JANE STREET GROUP, LLC ($8,311). Net institutional sentiment: Mixed.
See how CLDI's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer